Wright Medical Technology, Inc. Stryker Infinity Alignment Frame Distal Sub-Assembly, Catalog #33600020, non-sterile. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Stryker Infinity Alignment Frame Distal Sub-Assembly, Catalog #33600020, non-sterile.
Brand
Wright Medical Technology, Inc.
Lot Codes / Batch Numbers
Lot numbers 2656815 and 2762126, UDI-DI 00889797003926.
Products Sold
Lot numbers 2656815 and 2762126, UDI-DI 00889797003926.
Wright Medical Technology, Inc. is recalling Stryker Infinity Alignment Frame Distal Sub-Assembly, Catalog #33600020, non-sterile. due to The devices were manufactured with the pin sleeve holes too narrow, which does not allow the pin sleeves to pass through the pin sleeve holes, thereb. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
The devices were manufactured with the pin sleeve holes too narrow, which does not allow the pin sleeves to pass through the pin sleeve holes, thereby preventing pin placement through the pin holes.
Recommended Action
Per FDA guidance
The firm issued a Field Safety Correction Action (FSCA) Medical Devices Vigilance System form to the lead competent authority, ANSM-France, via email on 6/13/2023 for their review and approval for the recall to be carried out in their jurisdiction. The FSCA identified the affected product, a description of the issue, and advice on actions to be taken by the distributor and the user. The advice included to check the inventory to locate the product listed and remove and isolate/quarantine it to prevent accidental use. A business reply form was to be returned by email to confirm receipt of the notification and document product segregation. Upon receipt of the reply form, Stryker will contact the consignee for return of the product. If the devices have been distributed to other organizations, contact details are requested so that Stryker can inform the recipients appropriately. If the consignee is a distributor, they are responsible for notifying their affected customers. An undated recall letter accompanied the FSCA that will be issued once the lead competent authority approves it. The content of the letter was similar to the FSCA and contained a business reply form.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026